These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36686591)

  • 1. Tenofovir use is associated with a decreased risk of hepatocellular carcinoma among men with HIV irrespective of coinfection status.
    Lee MH; Wu PF; Chen TI; Chan C; Lin HH; Huang YH; Chen HY; Lin YT; Chen CJ
    JHEP Rep; 2023 Mar; 5(3):100634. PubMed ID: 36686591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection.
    Surial B; Ramírez Mena A; Roumet M; Limacher A; Smit C; Leleux O; Mocroft A; van der Valk M; Bonnet F; Peters L; Rockstroh JK; Günthard HF; Berzigotti A; Rauch A; Wandeler G; ; ; ;
    J Hepatol; 2023 May; 78(5):947-957. PubMed ID: 36690280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.
    Wandeler G; Mauron E; Atkinson A; Dufour JF; Kraus D; Reiss P; Peters L; Dabis F; Fehr J; Bernasconi E; van der Valk M; Smit C; Gjærde LK; Rockstroh J; Neau D; Bonnet F; Rauch A;
    J Hepatol; 2019 Aug; 71(2):274-280. PubMed ID: 30965070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral hepatitis in persons living with HIV in the post-COVID era.
    Soriano V; Moreno-Torres V; Mendoza C; Corral O; Barreiro P
    AIDS Rev; 2023; 25(1):1-13. PubMed ID: 36952663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of Hepatitis B Virus (HBV) Serologic Markers Among Antiretroviral-Naive Young People Living With Human Immunodeficiency Virus Who Had Undergone Neonatal HBV Vaccination and Initiated Antiretroviral Therapy.
    Huang YC; Sun HY; Sheng WH; Hsieh SM; Huang SH; Chen GJ; Liu WD; Chang SY; Su YC; Su LH; Liu WC; Hung CC
    Clin Infect Dis; 2022 Sep; 75(5):882-889. PubMed ID: 34893815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study.
    Jia J; Zhu Q; Deng L; Lan G; Johnson A; Chen H; Shen Z; Li J; Xing H; Ruan Y; Li J; Lu H; Vermund SH; Zhu J; Qian HZ
    Infect Dis Poverty; 2022 Jan; 11(1):7. PubMed ID: 34986877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Hepatitis B and HIV Coinfection: A Continuing Challenge in the Era of Antiretroviral Therapy.
    Kim HN
    Curr Hepatol Rep; 2020 Dec; 19(4):345-353. PubMed ID: 33796434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America.
    Kim HN; Newcomb CW; Carbonari DM; Roy JA; Torgersen J; Althoff KN; Kitahata MM; Reddy KR; Lim JK; Silverberg MJ; Mayor AM; Horberg MA; Cachay ER; Kirk GD; Sun J; Hull M; Gill MJ; Sterling TR; Kostman JR; Peters MG; Moore RD; Klein MB; Lo Re V;
    Hepatology; 2021 Sep; 74(3):1190-1202. PubMed ID: 33780007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for Hepatitis B Virus Prevention in People Living with HIV.
    Corcorran MA; Kim HN
    Curr HIV/AIDS Rep; 2023 Dec; 20(6):451-457. PubMed ID: 37837570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing Epidemiology of Hepatitis B Virus and Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus-Positive Population in China: Results From the Third and Fourth Nationwide Molecular Epidemiologic Surveys.
    Liu L; Wang L; Zhang H; Ou W; Li D; Feng Y; Zhuang H; Shao Y
    Clin Infect Dis; 2021 Aug; 73(4):642-649. PubMed ID: 34398954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
    Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
    JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.
    Lui GC; Hui VW; Sze SF; Wong BC; Cheung C; Lee MP; Yip TC; Tse YK; Lai JC; Chan HL; Wong VW; Hui YT; Wong GL
    Aliment Pharmacol Ther; 2023 Oct; 58(8):814-823. PubMed ID: 37515399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections.
    Sun HY; Cheng CY; Lin CY; Yang CJ; Lee NY; Liou BH; Tang HJ; Liu YM; Lee CY; Chen TC; Huang YC; Lee YT; Tsai MJ; Lu PL; Tsai HC; Wang NC; Hung TC; Cheng SH; Hung CC
    World J Gastroenterol; 2022 Mar; 28(11):1172-1183. PubMed ID: 35431505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
    Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
    Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.
    Wu HC; Jeng WJ; Pan MH; Hsieh YC; Lu SN; Chen CJ; Yang HI
    JHEP Rep; 2022 Feb; 4(2):100410. PubMed ID: 35079699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis B Virus-Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort.
    Dezanet LNC; Kassime R; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A
    Clin Infect Dis; 2022 Mar; 74(6):1012-1021. PubMed ID: 34197574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
    Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
    Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in HIV/HBV-Coinfected Patients in the Tenofovir Era Are Greatly Affected by Immune Suppression.
    Huang AJ; Núñez M
    J Int Assoc Provid AIDS Care; 2015; 14(4):360-8. PubMed ID: 25999329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.